相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination Long-Acting β-Agonists and Inhaled Corticosteroids Compared With Long-Acting β-Agonists Alone in Older Adults With Chronic Obstructive Pulmonary Disease
Andrea S. Gershon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Prehospital Use of Inhaled Corticosteroids and Point Prevalence of Pneumonia at the Time of Hospital Admission: Secondary Analysis of a Multicenter Cohort Study
Emir Festic et al.
MAYO CLINIC PROCEEDINGS (2014)
Influence of Previous Use of Inhaled Corticoids on the Development of Pleural Effusion in Community-acquired Pneumonia
Jacobo Sellares et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Prehospital use of inhaled steroids and incidence of acute lung injury among patients at risk
Emir Festic et al.
JOURNAL OF CRITICAL CARE (2013)
A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD
Edward M. Kerwin et al.
RESPIRATORY MEDICINE (2013)
Fluticasone furoate/vilanterol (100/25; 200/25 μg) improves lung function in COPD: A randomised trial
Fernando J. Martinez et al.
RESPIRATORY MEDICINE (2013)
Pneumonia and pneumonia related mortality in patients with COPD treated with fixed combinations of inhaled corticosteroid and long acting β2 agonist: observational matched cohort study (PATHOS)
Christer Janson et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol-fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study
Claus F. Vogelmeier et al.
LANCET RESPIRATORY MEDICINE (2013)
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials
Mark T. Dransfield et al.
LANCET RESPIRATORY MEDICINE (2013)
Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients
A. Liapikou et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Effect of budesonide/formoterol pMDI on COPD exacerbations: A double-blind, randomized study
Amir Sharafkhaneh et al.
RESPIRATORY MEDICINE (2012)
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
Dennis E. Doherty et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2012)
Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia
Dennis Chen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Reported Pneumonia in Patients With COPD Findings From the INSPIRE Study
Peter M. A. Calverley et al.
CHEST (2011)
Impact of inhaled corticosteroid use on outcome in COPD patients admitted with pneumonia
A. Singanayagam et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials
D. M. G. Halpin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Elevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy
Shih-Lung Cheng et al.
BMC PULMONARY MEDICINE (2011)
Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia
R. Malo de Molina et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Beclomethasone/formoterol in the management of COPD: A randomised controlled trial
P. M. A. Calverley et al.
RESPIRATORY MEDICINE (2010)
Inhaled corticosteroids and risk of pneumonia in newly diagnosed COPD
Min J. Joo et al.
RESPIRATORY MEDICINE (2010)
Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
Tobias Welte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Long-term Use of Inhaled Corticosteroids and the Risk of Pneumonia in Chronic Obstructive Pulmonary Disease A Meta-analysis
Sonal Singh et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes
Antonio Anzueto et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2009)
Translational research in the development of novel sepsis therapeutics: Logical deductive reasoning or mission impossible?
Steven M. Opal et al.
CRITICAL CARE MEDICINE (2009)
Efficacy and Tolerability of Budesonide/Formoterol in One Hydrofluoroalkane Pressurized Metered-Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease Results from a 1-Year Randomized Controlled Clinical Trial
Stephen I. Rennard et al.
DRUGS (2009)
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
C. Crim et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Budesonide and the risk of pneumonia: a meta-analysis of individual patient data
Don D. Sin et al.
LANCET (2009)
Efficacy and Safety of Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler in Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease Results of a 6-Month Randomized Clinical Trial
Donald P. Tashkin et al.
DRUGS (2008)
A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia
Fanny W. S. Ko et al.
RESPIRATORY MEDICINE (2008)
Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
Gary T. Ferguson et al.
RESPIRATORY MEDICINE (2008)
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia
Pierre Ernst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Twelve-week, randomized, placebo-controlled, Multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma
Jonathan Corren et al.
CLINICAL THERAPEUTICS (2007)
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial
Shawn D. Aaron et al.
ANNALS OF INTERNAL MEDICINE (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease
Peter Kardos et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Corticosteroid effects on cell signalling
PJ Barnes
EUROPEAN RESPIRATORY JOURNAL (2006)
Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma - A randomised clinical trial
Michael Noonan et al.
DRUGS (2006)
Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial
EFM Wouters et al.
THORAX (2005)
Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study
AL Sheffer et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)
Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease
PM Calverley et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
P Calverley et al.
LANCET (2003)
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
W Szafranski et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease - The COPE study
P van der Valk et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Effectiveness of fluticasone propionate and salmeterol combination delivered via the diskus device in them treatment of chronic obstructive pulmonary disease
DA Mahler et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Pharmacokinetics and systemic activity of fluticasone via Diskus® and pMDI, and of budesonide via Turbuhaler®
L Thorsson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome in breast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation
DS McGaughey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
PS Burge et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
分享论文
